Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5300

1.

Is autologous stem cell transplantation still relevant for multiple myeloma?

Choi T.

Curr Opin Hematol. 2019 Nov;26(6):386-391. doi: 10.1097/MOH.0000000000000538.

PMID:
31567432
2.

Efficacy of Gemcitabine on Intracranial Erlich Tumor and its Determinants.

Stukov AN, Bespalov VG, Alexandrov VA, Semenov AL, Kireeva GS, Semiglazova TY, Filatova LV, Baranenko DA.

Drug Res (Stuttg). 2019 Sep 25. doi: 10.1055/a-0824-6325. [Epub ahead of print]

PMID:
31556073
3.

LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation.

Colita A, Colita A, Bumbea H, Croitoru A, Orban C, Lipan LE, Craciun OG, Soare D, Ghimici C, Manolache R, Gelatu I, Vladareanu AM, Pasca S, Teodorescu P, Dima D, Lupu A, Coriu D, Tomuleasa C, Tanase A.

Front Oncol. 2019 Sep 10;9:892. doi: 10.3389/fonc.2019.00892. eCollection 2019.

4.

An autopsy case of widespread brain dissemination of glioblastoma unnoticed by magnetic resonance imaging after treatment with bevacizumab.

Hardian RF, Goto T, Kuwabara H, Hanaoka Y, Kobayashi S, Kanno H, Shimojo H, Horiuchi T, Hongo K.

Surg Neurol Int. 2019 Jul 5;10:137. doi: 10.25259/SNI-183-2019. eCollection 2019.

5.

Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour.

Ottaviano M, Maddalena C, D'Armiento M, Lauria R, D'Alessandro V, Tortora M, Matano E, Di Lauro V, Mucci B, Ferraro G, De Placido S, Giuliano M, Palmieri G.

Anticancer Drugs. 2019 Oct;30(9):959-963. doi: 10.1097/CAD.0000000000000806.

PMID:
31517734
6.

Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors.

Li C, Mishra AS, Gil S, Wang M, Georgakopoulou A, Papayannopoulou T, Hawkins RD, Lieber A.

Mol Ther. 2019 Aug 19. pii: S1525-0016(19)30366-1. doi: 10.1016/j.ymthe.2019.08.006. [Epub ahead of print]

PMID:
31494053
7.

miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.

Sippl C, Ketter R, Braun L, Teping F, Schoeneberger L, Kim YJ, List M, Nakhoda A, Wemmert S, Oertel J, Urbschat S.

Acta Neurochir (Wien). 2019 Sep 2. doi: 10.1007/s00701-019-04051-8. [Epub ahead of print]

PMID:
31478117
8.

Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.

Dietz AC, Seidel K, Leisenring WM, Mulrooney DA, Tersak JM, Glick RD, Burnweit CA, Green DM, Diller LR, Smith SA, Howell RM, Stovall M, Armstrong GT, Oeffinger KC, Robison LL, Termuhlen AM.

Lancet Oncol. 2019 Oct;20(10):1420-1431. doi: 10.1016/S1470-2045(19)30418-8. Epub 2019 Aug 27.

PMID:
31471158
9.

Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.

Gangaraju R, Chen Y, Hageman L, Wu J, Francisco L, Kung M, Ness E, Parman M, Weisdorf DJ, Forman SJ, Arora M, Armenian SH, Bhatia S.

Cancer. 2019 Aug 30. doi: 10.1002/cncr.32488. [Epub ahead of print]

PMID:
31469420
10.
11.

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.

Yerram P, Reiss SN, Modelevsky L, Gavrilovic IT, Kaley T.

J Neurooncol. 2019 Oct;145(1):57-63. doi: 10.1007/s11060-019-03266-0. Epub 2019 Aug 20.

PMID:
31432377
12.

Convection-Enhanced Delivery in Malignant Gliomas: A Review of Toxicity and Efficacy.

Shi M, Sanche L.

J Oncol. 2019 Jul 22;2019:9342796. doi: 10.1155/2019/9342796. eCollection 2019. Review.

13.

Fisetin effects on cell proliferation and apoptosis in glioma cells.

Pak F, Oztopcu-Vatan P.

Z Naturforsch C. 2019 Aug 17. pii: /j/znc.ahead-of-print/znc-2019-0098/znc-2019-0098.xml. doi: 10.1515/znc-2019-0098. [Epub ahead of print]

PMID:
31421049
14.

A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care.

Yi S, Yang F, Jie C, Zhang G.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3438-3447. doi: 10.1080/21691401.2019.1652628.

PMID:
31411066
15.

Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery.

Zhan W, Rodriguez Y Baena F, Dini D.

Drug Deliv. 2019 Dec;26(1):773-781. doi: 10.1080/10717544.2019.1639844.

16.

Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma.

Shabbir-Moosajee M, Jehangir S, Sawani S, Muhammed T, Ali N, Sheikh U, Adil S.

Blood Res. 2019 Jun;54(2):108-113. doi: 10.5045/br.2019.54.2.108. Epub 2019 Jun 25.

17.

The Role of Checkpoint Inhibitors in Glioblastoma.

Desai K, Hubben A, Ahluwalia M.

Target Oncol. 2019 Aug;14(4):375-394. doi: 10.1007/s11523-019-00655-3. Review.

PMID:
31290002
18.

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.

Saini NY, Patel RD, Varma A, Bashir Q, Delgado R, Rondon G, Mukherjee A, Popat U, Hosing C, Nieto Y, Kebriaei P, Weber DM, Thomas SK, Lee HC, Manasanch EE, Orlowski RZ, Champlin RE, Qazilbash MH, Patel KK.

Ann Hematol. 2019 Sep;98(9):2233-2235. doi: 10.1007/s00277-019-03734-7. Epub 2019 Jun 26. No abstract available.

PMID:
31243571
19.

Letter to the Editor. How safe is Carmustine wafer implantation?

Roux A, Zanello M, Zah-Bi G, Pallud J.

Rev Neurol (Paris). 2019 Jun 12. pii: S0035-3787(18)30945-7. doi: 10.1016/j.neurol.2018.12.009. [Epub ahead of print] No abstract available.

PMID:
31202441
20.

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol.

Roux A, Zanello M, Zah-Bi G, Pallud J.

Asian J Neurosurg. 2019 Apr-Jun;14(2):616-617. doi: 10.4103/ajns.AJNS_297_18. No abstract available.

Supplemental Content

Loading ...
Support Center